The global Regenerative Medicine Market was valued at USD 13.39 billion in 2016 and is projected to reach USD 89.75 billion by 2025, growing at a CAGR of 23.54% from 2017 to 2025.
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Availability of fund from Govt. and Private sector for development of regenerative medicine
1.2 Increasing cases of chronic diseases and genetic disorders
1.3 Increasing investments in global healthcare
1.4 Increase in corporate collaborations to enhance commercialization
2. Market Restraints
2.1 Ethical Concerns
2.2 Lack of Clear Regulatory Guidelines
Market Segmentation:
1. Global Regenerative MedicineMarket, by Therapy:
1.1 Cell Therapy
1.2 Tissue Engineering
1.3 Immunotherapy
1.4 Gene Therapy
2. Global Regenerative MedicineMarket, by Product:
2.1 Cell-Based Products
2.1.1 Allogeneic Products
2.1.2 Autologous Products
2.2 Acellular Products
3. Global Regenerative Medicine Market, by Application:
3.1 Orthopedic & Musculoskeletal Disorders
3.2 Dermatology
3.3 Cardiology
3.4 Central Nervous System Diseases
3.5 Oncology
3.6 Diabetes
3.7 Other Applications
4. Global Regenerative Medicine Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Acelity L.P. Inc. (KCI Licensing)
2. Nuvasive, Inc.
3. Vericel Corporation
4. Osiris Therapeutics, Inc.
5. Integra Lifesciences Corporation
6. Stryker Corporation
7. Medtronic PLC
8. Cook Biotech Incorporated
9. Organogenesis Inc.
10. Japan Tissue Engineering Co., Ltd. (Subsidiary of Fujifilm Holdings Corporation)
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Regenerative MedicineMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL REGENERATIVE MEDICINEMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL REGENERATIVE MEDICINEMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL REGENERATIVE MEDICINE MARKET, BY THERAPY
5.1 Cell Therapy
5.2 Tissue Engineering
5.3 Immunotherapy
5.4 Gene Therapy
6 GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT
6.1 Cell-Based Products
6.1.1 Allogeneic Products
6.1.2 Autologous Products
6.2 Acellular Products
7 GLOBAL REGENERATIVE MEDICINE MARKET, BY APPLICATION
7.1 Orthopedic & Musculoskeletal Disorders
7.2 Dermatology
7.3 Cardiology
7.4 Central Nervous System Diseases
7.5 Oncology
7.6 Diabetes
7.7 Other Applications
8 GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT
8.1 Consumables
8.2 Services
8.3 Software
9 GLOBAL REGENERATIVE MEDICINEMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL REGENERATIVE MEDICINEMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Acelity L.P. Inc. (KCI Licensing)
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Nuvasive, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Vericel Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Osiris Therapeutics, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Integra Lifesciences Corporation
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Stryker Corporation
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Medtronic PLC
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Cook Biotech Incorporated
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Organogenesis Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Japan Tissue Engineering Co., Ltd. (Subsidiary of Fujifilm Holdings Corporation)
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
Market Overview
The Asia Pacific Cryocooler Market is projected to experience robust growth from 2024 to 2034, driven by advancements in cooling technologies and increasing applications across various sectors. The market is expected to reach USD XX.XX billion by 2034, expanding at a com...
Market Overview
The Europe Cryocooler Market is poised for significant growth from 2024 to 2034, fueled by advancements in cryogenic technology and rising demand across various industrial and commercial applications. The market is expected to reach USD XX.XX billion by 2034, growing at ...
Market Overview
The North America Cryocooler Market is anticipated to witness robust growth from 2024 to 2034, driven by the increasing demand for efficient cooling solutions in diverse high-tech and industrial applications. By 2034, the market is projected to reach USD XX.XX billion, u...
Market Overview
The Global Cryocooler Market is expected to witness robust growth from 2024 to 2034, driven by increasing demands for cooling solutions in various high-tech and critical applications. Valued at USD XX.XX billion in 2024, the market is projected to expand to USD XX.XX bil...
Market Overview
The Asia Pacific Clinical Reference Laboratory Market is poised for substantial growth, driven by a surge in demand for advanced diagnostic services, the rising prevalence of chronic and infectious diseases, and increasing investments in healthcare infrastructure. Market...
Market Overview
The Europe Clinical Reference Laboratory Market is on the brink of significant growth, driven by the rising prevalence of chronic diseases, advancements in diagnostic technologies, and an increasing emphasis on precision medicine. Market research indicates that the Europ...